This inventor holds 2 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Columbia University, Maastricht University, Universitá Degli Studi Di Genova. Active years: 2018-2019.
Company Filing History:
1 out of 2,549 
1 out of 7 
1 out of 24 
Years Active: 2018-2019
Title: Jos Prickaerts: Innovator in Cognitive Treatment
Introduction
Jos Prickaerts is a notable inventor based in Maastricht, Netherlands. He has made significant contributions to the field of cognitive impairment treatment, holding two patents that focus on innovative therapeutic approaches.
Latest Patents
Prickaerts' latest patents include a method for treating cognitive impairment using a PDE4 inhibitor. This invention specifically addresses varying degrees of cognitive impairment associated with aging, Alzheimer's disease, and schizophrenia through the low-dose administration of roflumilast. Another patent involves compounds that exhibit selective PDE4D inhibiting activity, which can be utilized as a medicament for treating dementia, particularly Alzheimer's disease, and for enhancing memory.
Career Highlights
Throughout his career, Prickaerts has worked with esteemed institutions such as Maastricht University and Università Degli Studi di Genova. His research has focused on developing effective treatments for cognitive disorders, showcasing his commitment to advancing medical science.
Collaborations
Prickaerts has collaborated with notable colleagues, including Marlies Van Duinen and Anke Sambeth, contributing to a rich exchange of ideas and research in the field of cognitive health.
Conclusion
Jos Prickaerts stands out as an influential inventor in the realm of cognitive impairment treatment. His innovative patents and collaborations reflect his dedication to improving the lives of individuals affected by cognitive disorders.